Lentivirus-mediated shRNA targeting of cyclin D1 enhances the chemosensitivity of human gastric cancer to 5-fluorouracil
Authors:
- Eui-Suk JeongEJEui-Suk Jeong
- Kyoung-Sun LeeKLKyoung-Sun Lee
- Seung-Ho HeoSHSeung-Ho Heo
- Dong-Gu JeongDJDong-Gu Jeong
- Yang-Kyu ChoiYCYang-Kyu Choi
- 3 October 2013
- journal article
- Published by Spandidos Publications in International Journal of Oncology
- Vol. 43 (6) , 2007-2014
Abstract
Spandidos Publications is a scientific publisher with a long-standing international reputation for excellent standards and high quality science publicationsKeywords
This publication has 34 references indexed in Scilit:
- Benefit of Adjuvant Chemotherapy for Resectable Gastric CancerJAMA, 2010
- Chemotherapy for metastatic gastric cancer: past, present, and futureJournal of Gastroenterology, 2008
- Screening for gastric cancer in Asia: current evidence and practiceThe Lancet Oncology, 2008
- Adjuvant Chemotherapy for Gastric Cancer with S-1, an Oral FluoropyrimidineNew England Journal of Medicine, 2007
- Alteration of cyclin D1 in gastric carcinoma and its clinicopathologic significanceWorld Journal of Gastroenterology, 2004
- Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotoxicity to cisplatinum.Journal of Clinical Investigation, 1998
- Sensitivity to cis-diamminedichloroplatinum in human cancer cells is related to expression of cyclin D1 but not C-RAF-1 proteinInternational Journal of Cancer, 1996
- The retinoblastoma protein and cell cycle controlCell, 1995
- G1 phase progression: Cycling on cueCell, 1994
- Cyclin D and oncogenesisCurrent Opinion in Genetics & Development, 1993